Sonic Healthcare USA has launched a multiplex RT-PCR assay that combines testing for SARS-CoV-2 (COVID-19) and Influenza A/B with a single specimen collection.

Today, Sonic Healthcare USA (Sonic) was awarded a contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics Advanced Technology Platforms (RADx-ATP) initiative.

A new validation study published today, “Thyroid Cytology Smear Slides: An Untapped Resource for ThyroSeq Testing."

Over the last few weeks, our network of clinical laboratories throughout the United States has seen a significant increase in demand for COVID-19 molecular testing.

WASHINGTON, D.C – Following a surge of new COVID-19 cases in the United States, ACLA President Julie Khani issued the following statement:

Sonic Healthcare USA's Bernhardt Laboratories, located in Jacksonville, Florida, hosted U.S. Health and Human Services Secretary Alex Azar at their facility last week.  Bernhardt Laboratories is an...

Sonic Healthcare USA's COVID-19 Taskforce Medical and Scientific Advisors have developed a novel Return-to-Work protocol consisting of laboratory testing algorithms intended to help guide employers...

Sonic Healthcare USA's network of clinical laboratories has begun performing antibody testing for SARS-CoV-2 (COVID-19) to complement our existing molecular PCR testing. Sonic Healthcare USA labora...

Sonic Healthcare USA’s dedicated scientific, medical and operational experts have established SARS-CoV-2/COVID-19 testing in six of our laboratories across the country since March 10, 2020. Our res...

This week, Sonic Healthcare USA's network of clinical laboratories began testing for SARS-CoV-2 (COVID-19). Sonic Healthcare USA has worked closely with its scientific partners and medical and oper...

This week, Academic and Commercial Reference Laboratory Executives met with Vice President, Mike Pence and members of the White House's Coronavirus Task Force to collectively discuss diagnostic yes...

Sonic Healthcare USA (Sonic) and UPMC have entered into an exclusive long-term, 15-year license agreement for access to ThyroSeq® Genomic Classifier.  The test has already been commercially availab...

Validation of ThyroSeq® Genomic Classifier performance in an expanded range of sample types has been presented at the 28th Annual Scientific and Clinical Congress of the American Association of C...

Data from three studies demonstrating new diagnostic and therapeutic utility of ThyroSeq® Genomic Classifier, offered commercially by CBLPath, a Sonic Healthcare Company, are being presented at...

American Esoteric Laboratories (AEL), a division of Sonic Healthcare USA (Sonic Healthcare), has announced that it will be a Blue Cross and Blue Shield of Alabama (BCBSAL) Preferred Medical Labora...

Sonic Healthcare USA (Sonic Healthcare) and ProMedica Health System (ProMedica) announced that they have entered into a definitive agreement to form a joint venture to enhance laboratory services f...